Citrix Server Upgrade

The U.S. Food and Drug Administration is soliciting services to upgrade its Citrix Virtual Delivery Agent infrastructure from Windows Server 2016 to Windows Server 2019 to support the reinstallation and operation of the Empower 3.6.1 Client and NuGenesis 9.1 Client applications across laboratory sites in Detroit, Irvine, and Jamaica. The contractor must provide full vendor support for setup, configuration, installation, and qualification of two upgraded Citrix servers, ensuring compatibility and functionality of the Chromatographic Data Systems used in these locations. The work must be completed within 60 days of contract award under a one-year base period of performance, with all deliverables subject to inspection and acceptance at the designated location in Detroit, Michigan. Compliance with Section 508 of the Rehabilitation Act and WCAG 2.0 Level A and AA accessibility standards is mandatory, along with FIPS 140-2 encryption, HTTPS/HSTS implementation, and adherence to NIST SP 800-88 for electronic media sanitization. The acquisition is conducted as a Firm Fixed Price contract under the Lowest Price Technically Acceptable (LPTA) method, where technical conformance is a mandatory pass/fail criterion and award will go to the lowest-priced offeror meeting all requirements. All proposals must demonstrate complete technical conformance with the solicitation and include pricing, representations, and certifications. Contractors must comply with stringent security requirements including HSPD-12, FIPS 201, and OMB M-05-24, requiring background investigations for personnel and submission of an updated staff roster with full identification and responsibilities. All personnel must complete FDA-mandated security, privacy, and records management training prior to commencement and annually thereafter. Invoices must be submitted electronically via Treasury’s Invoice Processing Platform, and any security or PII breaches must be reported within one hour of discovery. The contract incorporates numerous FAR and HHSAR clauses covering commercial item acquisition, software licensing, payment procedures, cybersecurity prohibitions, and electronic information accessibility, with no physical packaging, marking, or bar-coding standards specified. The solicitation number is FDA-75F40126Q00166, with a response deadline of June 18, 2026, and primary point of contact is Tiffany Gates of the FDA Office of Acquisitions, Grants, and Services.